{
    "1preterm-labour-and-birth-pdf-1837333576645.pdf": "Here are the most significant terms extracted from the provided text:\n\n1. NICE\n2. National Institute for Health and Care Excellence\n3. Preterm labour and birth\n4. NICE guideline\n5. Preterm\n6. Labour\n7. Published\n8. Evidence\n9. Patients\n10. Yellow Card Scheme\n11. Medicine\n12. Healthcare\n13. Adverse events\n14. Regulatory Agency\n15. Local Commissioners\n16. Healthcare Providers\n17. Environmental Impact\n18. Funding and Services\n19. Prophylactic vaginal progesterone\n20. Cervical cerclage\n21. Prelabour rupture of membranes (P-PROM)\n22. Antenatal antibiotics\n23. Infection\n24. Tocolysis\n25. Maternal corticosteroids\n26. Magnesium sulfate\n27. Neuroprotection\n28. Fetal monitoring\n29. Cord clamping\n30. Cervical trauma\n31. MBRRACE-UK\n32. Research\n33. Neonatal care\n34. Diagnostic tests\n35. Obstetrician\n36. Paediatrician \n37. Effective treatment\n38. Risk factors\n39. Healthcare Professionals\n40. Gestational age\n41. Intrapartum antibiotics\n42. Maternal corticosteroids\n43. Repeat courses\n44. Neurodevelopmental outcomes\n45. Health inequalities\n46. Corticosteroids\n47. Preclinical trials\n48. Infant Mortality\n49. Neonatal Unit",
    "BJOG - 2016 -  - Management of Premenstrual Syndrome.pdf": "1. Premenstrual Syndrome (PMS)\n2. Gonadotrophin-releasing hormone (GnRH) analogues\n3. Selective serotonin reuptake inhibitors (SSRIs)\n4. Combined oral contraceptives (COCs)\n5. Cognitive behavioural therapy (CBT)\n6. Drospirenone-containing COCs\n7. Transdermal estradiol\n8. Micronised progesterone\n9. Levonorgestrel-releasing intrauterine system (LNG-IUS)\n10. Danazol\n11. Hysterectomy and bilateral oophorectomy\n12. Bone mineral density (BMD)\n13. Daily Record of Severity of Problems (DRSP)\n14. Evidence levels and recommendation grades\n15. Royal College of Obstetricians and Gynaecologists (RCOG)\n16. Premenstrual dysphoric disorder (PMDD)\n17. National Association for Premenstrual Syndrome (NAPS)\n18. Premenstrual exacerbation\n19. Progestogen-induced premenstrual disorder\n20. Estradiol therapy",
    "gtg_5_ohss.pdf": "1. Ovarian Hyperstimulation Syndrome (OHSS)\n2. Fertility treatment\n3. Symptoms and signs of OHSS\n4. Diagnosis\n5. Clinical criteria\n6. Outpatient management\n7. Inpatient management\n8. Thromboprophylaxis\n9. Paracentesis\n10. Fluid balance\n11. Ascites\n12. Human Fertilisation and Embryology Authority (HFEA)\n13. Severity classification\n14. Incidence\n15. Risk factors\n16. Thromboembolism (VTE)\n17. GnRH antagonists\n18. Dopamine agonists\n19. Fluid replacement\n20. Intensive care\n21. Pregnancy complications\n22. Royal College of Obstetricians and Gynaecologists (RCOG)\n23. Management protocols\n24. NICE accredited\n25. Assisted reproductive technology (ART)"
}